Effective disopyramide treatment in a boy with mid-ventricular hypertrophic obstructive cardiomyopathy

Circulation Journal

Volumn 66, Issue 7, 2002, Pages 709-711

  Teraguchi, Masayuki ^a   Ikemoto, Yumiko ^a   Kobayashi, Yohnosuke ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

123I methyl iodophenyl pentadecanoic acid (BMIPP) myocardial scintigraphy; Disopyramide; Mid ventricular hypertrophic obstructive cardiomyopathy; Pediatrics

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; DISOPYRAMIDE; PROPRANOLOL; ANTIARRHYTHMIC AGENT;

ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DYSPNEA; HEART SCINTISCANNING; HEART VENTRICULOGRAPHY; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; PRESSURE GRADIENT; THORAX PAIN; TWO DIMENSIONAL ECHOCARDIOGRAPHY; CHILD; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HEART VENTRICLE; HYPERTROPHIC CARDIOMYOPATHY; PATHOLOGY;

ANTI-ARRHYTHMIA AGENTS; CARDIOMYOPATHY, HYPERTROPHIC; CHEST PAIN; CHILD; DISOPYRAMIDE; HEART VENTRICLES; HUMANS; MALE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036307253     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.66.709     Document Type: Article

References (15)

1. Mid-ventricular obstruction: A variant of obstructive cardiomyopathy
2. Hypertrophic cardiomyopathy: The importance of the site and extent of hypertrophy
3. Noninvasive evaluation of mid-left ventricular obstruction by two-dimensional and Doppler echocardiography and color flow Doppler echocardiography
4. Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy
5. An atypical variant of Fabry's disease in men with left ventricular hypertrophy
6. Clinically significant cardiac amyloidosis
7. Glycogen storage disease associated with left ventricular aneurysm in an elderly patient
8. Differential diagnosis of hypertrophic cardiomyopathies: Typical (subaortic) hypertrophic obstructive cardiomyopathy, atypical (mid-ventricular) hypertrophic obstructive cardiomyopathy and hypertrophic nonobstructive cardiomyopathy
9. Hypertrophic cardiomyopathy: Clinical spectrum and treatment
10. Muscular subaortic stenosis: Hemodynamic and clinical improvement after disopyramide
11. Dynamic outflow obstruction due to transient extensive left ventricular wall motion abnormalities caused by acute myocarditis in a patient with hypertrophic cardiomyopathy: Reduction in ventricular afterload by disopyramide
12. Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy
13. 123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography
14. Scintigraphic evidence for a specific long-chain fatty acid transporting system and the genetic background in a patient with hypertrophic cardiomyopathy
15. Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: High incidence in patients with midventricular obstruction